GKSL Corrects Typographical Error in Standalone Financial Statements Signing Date
GKSL clarifies a typographical error in the signing date of its Standalone Financial Statements. The correct signing date was May 28, 2025. The company will upload corrected statements online and assures no impact on financial figures.
The announcement addresses a clerical error in a date, which has no bearing on the company's financial performance or future outlook. Hence, the impact is low.
The announcement is a clarification of a minor typographical error with no impact on the financial figures or substance of the results. Therefore, the sentiment is neutral.
Gujarat Kidney And Super Speciality Limited (GKSL) has issued a clarification regarding a deficiency observation by the National Stock Exchange of India Limited concerning its financial results submitted on May 28, 2026. The company identified a typographical/clerical error in the signing date of the Standalone Financial Statements (SFS). The actual date of signing was May 28, 2025, not the date previously indicated.
GKSL will publish the corrected Standalone Financial Statements with the accurate signing date on its website, www.gujaratsuperspecialityhospital.com, at the earliest. The company assures that this error was inadvertent and does not affect the financial figures, disclosures, or the substance of the financial results. Internal checks will be enhanced to prevent future typographical errors.
The company regrets any inconvenience caused and reaffirms its commitment to complying with SEBI LODR Regulations. The corrected copy of the Standalone Financial Statements has been enclosed with the submission.
What to do with a filing like this
Gujarat Kidney And Super Speciality Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Kidney And Super Speciality Limited. Read the original for the full detail.